When you search Botox vs Dysport vs Xeomin, you are usually trying to make a practical decision: which wrinkle treatment may fit your goals, treatment area, timing, and previous experience? These three prescription neuromodulators are related, but their labels, formulations, dosing units, and cosmetic indications are not identical.
Botox Cosmetic, Dysport, and Xeomin all temporarily reduce selected muscle activity to soften certain dynamic facial lines. There is no universal winner. A qualified injector should match the product and dose to your facial anatomy, treatment goal, medical history, prior response, and the specific area being treated.
This guide explains the differences without treating marketing claims as guarantees. It also shows why product units cannot be compared one-for-one and which questions to bring to a Texas consultation.
What are Botox, Dysport, and Xeomin?
Botox Cosmetic, Dysport, and Xeomin are prescription botulinum toxin type A products used for specific medical and cosmetic indications. Each temporarily interrupts nerve-to-muscle signaling in a targeted area. The result can be softer expression lines, but the products are not interchangeable and do not treat every type of wrinkle.
Dynamic wrinkles appear or become more pronounced when facial muscles contract. A neuromodulator reduces activity in selected muscles, which can soften the appearance of lines that are strongly connected to movement. It does not replace lost facial volume, erase every etched-in line, or improve all skin texture concerns.
The brand names refer to distinct products:
- Botox Cosmetic contains onabotulinumtoxinA.
- Dysport contains abobotulinumtoxinA.
- Xeomin contains incobotulinumtoxinA.
The official prescribing information for all three products includes a warning that botulinum toxin effects can spread beyond the injection area. The FDA labels also state that potency units are not interchangeable between products. Review the FDA Botox Cosmetic label, FDA Dysport label, and FDA Xeomin label for complete prescribing information.
How do the formulations differ?
Botox Cosmetic, Dysport, and Xeomin use different active drug names and formulation details. Xeomin is incobotulinumtoxinA, Dysport is abobotulinumtoxinA, and Botox Cosmetic is onabotulinumtoxinA. These differences may matter during product selection, but they do not make one option automatically safer, faster, or better for every patient.
It is tempting to reduce the comparison to a slogan such as “cleaner,” “faster,” or “more precise.” Those labels oversimplify a prescription treatment decision. The product is only one part of the result. Injection placement, dose, muscle strength, facial proportions, treatment area, and the injector’s technique all influence what a patient experiences.
Xeomin is often discussed because its formulation does not include the same accessory complexing proteins associated with some other botulinum toxin products. That formulation difference can be a reasonable question for a consultation, but it should not be turned into a promise that Xeomin will prevent every adverse reaction or solve every case of reduced response.
Dysport and Botox Cosmetic also have different labeled cosmetic indications and unit systems. A larger number printed on a Dysport treatment plan does not mean the dose is stronger or the treatment is more expensive. The products use different potency units, so a clinician must select the dose for that product and area. Never convert units yourself or compare a price per unit without asking what the total treatment plan includes.
Which cosmetic areas are covered by each product?
The FDA-approved cosmetic areas are not identical. Botox Cosmetic is labeled for glabellar, forehead, lateral canthal, and platysma lines in adults. Dysport is labeled for glabellar lines in adults younger than 65. Xeomin is labeled for glabellar, horizontal forehead, and lateral canthal lines in adults.
“Labeled” means the indication appears in the product’s FDA-approved prescribing information. It does not mean that every patient is a candidate or that an off-label discussion is automatically appropriate. The injector should evaluate the anatomy, muscle movement, skin quality, medical history, and intended result before recommending any injection plan.
| Product | Active ingredient | FDA-labeled cosmetic areas in the cited label | What to clarify |
|---|---|---|---|
| Botox Cosmetic | OnabotulinumtoxinA | Glabellar lines, lateral canthal lines, forehead lines, and platysma bands in adults | Which areas are appropriate together and how will the plan preserve natural expression? |
| Dysport | AbobotulinumtoxinA | Moderate to severe glabellar lines in adults younger than 65 | Is the selected indication and dose appropriate for your age, anatomy, and goal? |
| Xeomin | IncobotulinumtoxinA | Glabellar lines, horizontal forehead lines, and lateral canthal lines in adults | How does the formulation fit your past treatment response and planned treatment area? |
This table is a starting point, not a treatment recommendation. The labels can change, and a clinician may discuss options based on current product availability, professional judgment, and your individual circumstances.
How quickly do results appear, and how long do they last?
Most neuromodulator results develop over several days rather than appearing immediately, with the final effect assessed after additional time. Duration varies with the product, dose, treated muscle, metabolism, treatment history, and individual response. Botox Cosmetic, Dysport, and Xeomin should not be chosen solely on a promised onset or duration.
Patients often ask whether Dysport is always faster, Botox always lasts longer, or Xeomin always wears off sooner. Those statements are too absolute. A 2016 randomized clinical trial comparing onabotulinumtoxinA, abobotulinumtoxinA, and incobotulinumtoxinA in the glabella found differences at some early measurements, while pairwise differences were not significant at the 90-day measurement. The study used specific doses and a particular patient group, so it should not be treated as a guarantee for an individual.
You can read the study abstract, A Quantitative Analysis of OnabotulinumtoxinA, AbobotulinumtoxinA, and IncobotulinumtoxinA, for its methods and limitations. It supports a useful takeaway: brand comparisons are more complicated than a single “fastest” or “longest-lasting” ranking.
For planning purposes, ask:
- When should I expect the first visible change?
- When will we assess the full result?
- How often do you recommend reassessment or repeat treatment?
- What will we do if one area responds differently from another?
Schedule timing also matters. If you have an event, travel, or photography deadline, tell the injector early. Building in time for the result to develop and for a clinician to assess the outcome is more reliable than choosing a product from an internet timeline.
Book your consultation to discuss your treatment timeline
How should you compare cost?
There is no responsible way to name a universal winner on cost. Botox Cosmetic, Dysport, and Xeomin use different unit systems, and clinics may price by unit, area, session, or treatment plan. Compare the total plan, the treated areas, the dose, follow-up policy, and injector qualifications rather than a single advertised unit price.
A lower price per unit does not necessarily mean a lower total cost. Dysport units cannot be exchanged for Botox Cosmetic or Xeomin units, so the unit count alone is not a useful comparison. A quote should make clear which product is being used, which areas are included, what the recommended dose is, and whether a follow-up visit is part of the plan.
During a consultation, ask for the information in writing:
- Which product and active ingredient are recommended?
- Which facial areas are included?
- What is the total fee for the proposed plan?
- Are follow-up assessment or touch-up policies explained?
- What alternatives could meet the same goal?
Ultimate Image MedSpa’s consultation team can explain current treatment availability and the factors that shape a personalized plan. Because product availability and pricing can change, confirm current details directly rather than relying on an older article or a competitor’s promotion.
Which option may fit your goals?
The best choice depends on what you want to improve, where the lines appear, how much movement you want to preserve, your prior response, and the product options available from your qualified injector. Botox Cosmetic may be discussed for several labeled facial areas, while Dysport and Xeomin have their own labeled indications and formulation considerations.
Use your goal as the starting point, not the brand name:
If you want a targeted change
Tell the injector which lines bother you and which expressions you want to keep. The plan should account for the surrounding muscles and the way your face moves, not simply treat every visible line. “Natural” is not a product guarantee. It is the result of appropriate assessment, conservative planning, and careful technique.
If you want to treat more than one area
Ask how the areas interact. Forehead, glabellar, and eye-area treatment may require a coordinated plan because changing one muscle group can affect the visual balance of another. The FDA labels describe different indications, so ask which product and areas are being recommended and why.
If you have had a short or uneven response before
Share the product name, approximate treatment date, areas treated, dose if known, and what you noticed. A short response does not automatically prove resistance or mean that switching products will solve the issue. The injector may need to review timing, dose, placement, muscle activity, storage, and other clinical factors.
If you are new to neuromodulators
Bring questions instead of choosing by social media ranking. A first appointment should cover your goals, medical history, medications, allergies, previous procedures, expected timeline, risks, alternatives, and aftercare. You should have enough information to decide whether to proceed, not pressure to select a brand immediately.
Are Botox, Dysport, and Xeomin safe for everyone?
Botox Cosmetic, Dysport, and Xeomin are prescription treatments with contraindications, warnings, and potential adverse reactions. A consultation should include medical history, medications, allergies, neuromuscular conditions, pregnancy or breastfeeding considerations, prior injections, and the planned treatment area. A licensed medical professional should determine whether treatment is appropriate.
Do not use an online comparison chart as a substitute for screening. Tell your provider about any history of neuromuscular disease, swallowing or breathing problems, facial weakness, prior reactions to botulinum toxin, infection at the proposed injection site, or medications that could affect neuromuscular transmission. Also disclose pregnancy or breastfeeding and any recent facial procedures so the clinician can advise you appropriately.
The FDA boxed warnings for these products explain that toxin effects can spread from the injection area and may cause serious swallowing or breathing difficulties. These events are uncommon, but the warning is important. Seek urgent medical attention for serious or unusual symptoms after treatment, and follow the specific aftercare and emergency guidance given by your provider.
Commonly discussed temporary effects can include injection-site discomfort, bruising, swelling, headache, or changes in nearby muscle activity. The type and frequency of adverse reactions vary by product and treatment area. Ask which effects are expected, which need a call to the clinic, and which require urgent care.
What happens during a neuromodulator consultation?
A thorough consultation connects your desired result with facial anatomy, medical history, treatment options, and realistic timing. The provider should examine movement patterns, explain the proposed areas and dose, review risks and alternatives, answer cost questions, and give you time to decide. Treatment should never be based on a brand name alone.
At Ultimate Image MedSpa, the consultation is intended to help clients understand their options before choosing a treatment plan. The conversation may include:
- Your goals: Explain which lines or expressions you want to soften and how much movement you want to preserve.
- Facial assessment: The provider evaluates muscle movement, asymmetry, skin quality, and the relationship between the requested areas.
- Medical screening: Share conditions, medications, allergies, prior injections, and any relevant changes in your health.
- Option comparison: Ask why a particular product, area, dose, and timing were recommended, and what alternatives exist.
- Plan and aftercare: Confirm the total cost, timeline, expected follow-up, precautions, and who to contact with questions.
If you are comparing Botox vs Dysport vs Xeomin, bring the product name and treatment history from any previous appointment. Clear records help the injector evaluate your experience without guessing. You can also review the existing Botox vs Dysport comparison guide and the Botox consultation guide before your visit. This three-way article adds Xeomin and focuses on the questions that make a product comparison useful.
Book your consultation to compare your wrinkle treatment options
Frequently Asked Questions
Botox Cosmetic, Dysport, and Xeomin can all be part of a wrinkle-treatment conversation, but the right option depends on the person and the treatment area. Their units are not interchangeable, their FDA-labeled cosmetic indications differ, and timing or duration varies. A qualified consultation is the safest way to compare them.
Which lasts longer, Xeomin or Botox?
Neither should be promised as the longer-lasting option for every patient. Duration varies with the product, dose, muscle, treatment area, metabolism, and individual response. Ask your injector how your treatment history and goals affect the expected reassessment and repeat-treatment timeline.
Does Xeomin last longer than Dysport?
There is no universal answer. Xeomin and Dysport are different products with different potency units and formulations. A clinician should review the intended area, previous response, dose, and timing rather than relying on a generic ranking or an online unit conversion.
Why do people prefer Botox over Dysport?
Some patients prefer a familiar brand or a plan that matches their prior experience, while others may discuss Dysport for a different treatment approach. Preference does not establish that one product is better. The decision should follow an assessment of anatomy, goals, product availability, and safety considerations.
Are Botox, Dysport, and Xeomin units interchangeable?
No. The FDA prescribing information for each product warns that its potency units cannot be compared or converted directly to units of other botulinum toxin products. Never choose a dose or compare a quote using an internet conversion chart.
How do I choose between Botox, Dysport, and Xeomin?
Start with the result and area you want to address. Then discuss your anatomy, medical history, previous treatment response, timing, cost, and the product options available from your qualified injector. The consultation should explain the recommendation and alternatives clearly.
Sources and medical disclaimer
This article is educational and is not a diagnosis, prescription, or substitute for an examination. Product labels, indications, and availability can change. Use the FDA prescribing information and a qualified medical professional as the authority for your personal treatment decision.
Sources reviewed include the FDA Botox Cosmetic label, FDA Dysport label, FDA Xeomin label, and a randomized clinical trial comparing three botulinum toxin type A formulations. Always follow the instructions and emergency guidance provided by your treating professional.
